|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07K 16/28 |
| (11) | Number of the document | 3024851 |
| (13) | Kind of document | T |
| (96) | European patent application number | 14748461.2 |
| Date of filing the European patent application | 2014-07-25 | |
| (97) | Date of publication of the European application | 2016-06-01 |
| (45) | Date of publication and mention of the grant of the patent | 2018-05-09 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2014/048289 |
| Date | 2014-07-25 |
| (87) | Number | WO 2015/013671 |
| Date | 2015-01-29 |
| (30) | Number | Date | Country code |
| 201361858402 P | 2013-07-25 | US |
| (72) |
IRVING, Bryan Allen, US
HOSTETTER, Daniel Robert, US
WONG, Chihong, US
LOWMAN, Henry Bernard, US
WEST, James William, US
LA PORTE, Sherry Lynn, US
|
| (73) |
CytomX Therapeutics, Inc.,
151 Oyster Point Blvd, Suite 400, South San Francisco, CA 94080,
US
|
| (54) | MULTISPECIFIC ANTIBODIES, MULTISPECIFIC ACTIVATABLE ANTIBODIES AND METHODS OF USING THE SAME |
| MULTISPECIFIC ANTIBODIES, MULTISPECIFIC ACTIVATABLE ANTIBODIES AND METHODS OF USING THE SAME |